1.
Suhardi KF, Sutadji JC, Putri AR, Tsamara G, Faratisha IFD, Viazelda AT, et al. Empagliflozin for liver and lipid profile in metabolic dysfunction-associated fatty liver disease: a meta-analysis. Med J Indones [Internet]. 2025 Nov. 27 [cited 2025 Dec. 6];1(1). Available from: https://mji.ui.ac.id/journal/index.php/mji/article/view/7855